Table 1.
The relationship between JMJD8 expression and clinicopathological parameters of NSCLC
| Clinicopathological characteristics | Total N | JMJD8-negative | JMJD8-positive | P-value |
|---|---|---|---|---|
| Age (years) | ||||
| ≤60 | 89 | 36 | 53 | 0.550 |
| >60 | 80 | 36 | 44 | |
| Gender | ||||
| Male | 126 | 48 | 78 | 0.042 |
| Female | 43 | 24 | 19 | |
| Histological type | ||||
| Squamous cell carcinoma | 92 | 53 | 39 | <0.01 |
| Adenocarcinoma | 77 | 19 | 58 | |
| Differentiation | ||||
| Well-Moderate | 94 | 51 | 43 | <0.01 |
| Poor | 75 | 21 | 54 | |
| Tumor size (cm) | ||||
| ≤3 | 94 | 33 | 61 | 0.027 |
| >3 | 75 | 39 | 36 | |
| Lymph node metastasis | ||||
| Negative | 88 | 43 | 45 | 0.086 |
| Positive | 81 | 29 | 52 | |
| TNM stage | ||||
| I | 68 | 36 | 32 | 0.026 |
| II-III | 101 | 36 | 65 |
NSCLC, non-small cell lung cancer.